R&D Pipeline
In our efforts to bring standardised T cell testing to the masses, ImmunoServ have an extensive R&D pipeline utilising the Immuno-T™ platform to address a number of disease areas where T cells play a critical role in pathogenesis. Together with our project collaborators and funders, our aim is to promote patient and public health through the development of innovative new Immuno-T tests with significant prognostic and diagnostic potential.
If you are interested in partnering with us on any of these indications, or have other potential indications for Immuno-T, please contact the team here.
Expanding Contract Research Services
ImmunoServ has a growing reputation for providing high-quality contract research services in the immunology field. Our current laboratory services encompass bespoke assays that utilise a broad range of techniques and analytical platforms. We are continuously expanding our portfolio and investing in innovative new services to improve our contract research capabilities. For example, we are currently developing services for the provision of 3D organoid systems.
If you're interested in our contract research services please contact us to discuss your requirements.
Keep up to date with our latest news, research and announcements by subscribing to our newsletter:
Thanks for subscribing! Please check your email for further instructions.